5/16/2006 – Nanosphere Inc. raised a $57 million fourth round to commercialize a nucleic acid- and protein-detection technology with potential to expand the use of biomarkers in disease diagnosis and treatment.
5/16/2006 – Nanosphere Inc. raised a $57 million fourth round to commercialize a nucleic acid- and protein-detection technology with potential to expand the use of biomarkers in disease diagnosis and treatment.
